The treatment of rheumatic endocarditis

Слайд 2

Plan: 1.Treatment of rheumatic endocarditis 2.Test

Plan: 1.Treatment of rheumatic endocarditis 2.Test

Слайд 3

Endocarditis Treatment Endocarditis Treatment is often difficult, the inability to quickly establish a

Endocarditis Treatment Endocarditis Treatment is often difficult, the inability to quickly establish
diagnosis. In addition, the pathology may be "masked" for other syndromes. It is possible to identify the main trends that are used in the treatment of patients with:

Слайд 4

Antibiotic therapy Microbicides used in high doses by intravenous drip. the use of

Antibiotic therapy Microbicides used in high doses by intravenous drip. the use
one drug are often ineffective, then use a combination of drugs. Depending on the pathogen used: benzyl penicillin, gentamicin and amikacin intramuscularly (viridans streptococcus infection); semisynthetic penicillins in combination with cephalosporins or aminoglycosides (with staphylococcal endocarditis);

Слайд 5

intolerance to penicillins macrolides can be given; Vancomycin has high efficiency and

intolerance to penicillins macrolides can be given; Vancomycin has high efficiency and
fluoroquinolones; Treatment with amphotericin B antifungal antibiotic. Mandatory requirement - the continuity and duration of treatment.

Слайд 6

Immunotherapy Apply passive immunization to neutralize circulating in the bloodstream microbial toxins ready

Immunotherapy Apply passive immunization to neutralize circulating in the bloodstream microbial toxins
antitoxic sera. The most effective hyperimmune plasma and human immunoglobulin which is administered intravenously daily for 3-5 days.

Слайд 7

Surgery The surgical technique involves the mechanical removal of intracardiac foci of infection

Surgery The surgical technique involves the mechanical removal of intracardiac foci of
and the affected valve structures with subsequent reconstruction and implantation of artificial mechanical or biological prosthesis. Implemented in the event of failure of conservative treatment of developing heart failure, myocardial abscess, arterial thromboembolism, fungal endocarditis, and other adverse outcomes of therapy.